<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Publishing DTD v3.0 20080202//EN" "journalpublishing3.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="en" article-type="research-article">
<?release-delay 0|0?>
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">BR</journal-id>
<journal-title-group>
<journal-title>Biomedical Reports</journal-title>
</journal-title-group>
<issn pub-type="ppub">2049-9434</issn>
<issn pub-type="epub">2049-9442</issn>
<publisher>
<publisher-name>D.A. Spandidos</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="publisher-id">BR-23-2-02001</article-id>
<article-id pub-id-type="doi">10.3892/br.2025.2001</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Articles</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Effect of <italic>Gracilaria fisheri</italic> sulfated galactan with increased sulfation on cell migration and expression of cell adhesion molecules in sodium oxalate-induced HK-2 cell injury</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name><surname>Rudtanatip</surname><given-names>Tawut</given-names></name>
<xref rid="af1-BR-23-2-02001" ref-type="aff">1</xref>
</contrib>
<contrib contrib-type="author">
<name><surname>Phanphak</surname><given-names>Jenjiralai</given-names></name>
<xref rid="af1-BR-23-2-02001" ref-type="aff">1</xref>
</contrib>
<contrib contrib-type="author">
<name><surname>Somintara</surname><given-names>Somsuda</given-names></name>
<xref rid="af1-BR-23-2-02001" ref-type="aff">1</xref>
</contrib>
<contrib contrib-type="author">
<name><surname>El-Abid</surname><given-names>Jamal</given-names></name>
<xref rid="af2-BR-23-2-02001" ref-type="aff">2</xref>
</contrib>
<contrib contrib-type="author">
<name><surname>Wongprasert</surname><given-names>Kanokpan</given-names></name>
<xref rid="af3-BR-23-2-02001" ref-type="aff">3</xref>
</contrib>
<contrib contrib-type="author">
<name><surname>Kovensky</surname><given-names>Jos&#x00E9;</given-names></name>
<xref rid="af4-BR-23-2-02001" ref-type="aff">4</xref>
</contrib>
<contrib contrib-type="author" corresp="yes">
<name><surname>Sakaew</surname><given-names>Waraporn</given-names></name>
<xref rid="af1-BR-23-2-02001" ref-type="aff">1</xref>
<xref rid="c1-BR-23-2-02001" ref-type="corresp"/>
</contrib>
</contrib-group>
<aff id="af1-BR-23-2-02001"><label>1</label>Electron Microscopy Unit, Department of Anatomy, Faculty of Medicine, Khon Kaen University, Mueang, Khon Kaen 40002, Thailand</aff>
<aff id="af2-BR-23-2-02001"><label>2</label>Department of Organic Chemistry, Arrhenius Laboratory, Stockholm University, Svante Arrhenius V&#x00E4;g 16C 10691, Stockholm, Sweden</aff>
<aff id="af3-BR-23-2-02001"><label>3</label>Department of Anatomy, Faculty of Science, Mahidol University, Phaya Thai, Bangkok 10400, Thailand</aff>
<aff id="af4-BR-23-2-02001"><label>4</label>Laboratoire de Glycochimie, des Antimicrobiens et des Agroressources (LG2A) CNRS UMR 7378, Universit&#x00E9; de Picardie Jules Verne, Amiens 80039, France</aff>
<author-notes>
<corresp id="c1-BR-23-2-02001"><italic>Correspondence to:</italic> Dr Waraporn Sakaew, Electron Microscopy Unit, Department of Anatomy, Faculty of Medicine, Khon Kaen University, 123 Moo 16 Mittraphap Road, Mueang, Khon Kaen 40002, Thailand <email>warapsa@kku.ac.th</email></corresp>
</author-notes>
<pub-date pub-type="collection"><month>08</month><year>2025</year></pub-date>
<pub-date pub-type="epub"><day>22</day><month>05</month><year>2025</year></pub-date>
<volume>23</volume>
<issue>2</issue>
<elocation-id>123</elocation-id>
<history>
<date date-type="received">
<day>07</day>
<month>02</month>
<year>2025</year>
</date>
<date date-type="accepted">
<day>03</day>
<month>04</month>
<year>2025</year>
</date>
</history>
<permissions>
<copyright-statement>Copyright: &#x00A9; 2025 Rudtanatip et al.</copyright-statement>
<copyright-year>2025</copyright-year>
<license license-type="open-access">
<license-p>This is an open access article distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/">Creative Commons Attribution-NonCommercial-NoDerivs License</ext-link>, which permits use and distribution in any medium, provided the original work is properly cited, the use is non-commercial and no modifications or adaptations are made.</license-p></license>
</permissions>
<abstract>
<p>Exposure to oxalate crystals causes cellular injury and dysfunction in the renal tubular epithelium. Sulfated galactan with increased sulfation (SGS) from the red seaweed <italic>Gracilaria fisheri</italic> exhibits anti-urolithiasis effects by inhibiting oxalate crystal formation and preventing sodium oxalate (NaOX)-induced death of renal tubular (HK-2) cells. However, the effects of SGS on wound healing and adhesion molecule expression in NaOX-induced HK-2 cell injury remain unexplored. The present study investigated the effects of SGS on wound healing and the regulation of adhesion molecule expression in NaOX-induced HK-2 cell damage. The findings showed that SGS promoted wound healing in HK-2 cells following a scratch injury under NaOX-induced conditions. NaOX exposure increased the expression of CD44 and vimentin while decreasing the expression of EpCAM, E-cadherin, occludin and ZO-1, as demonstrated by reverse transcription-quantitative PCR, western blotting and immunofluorescence analysis. Treatment with SGS restored these adhesion molecule expression levels to near normal. Scanning electron microscopy revealed that SGS also reversed NaOX-induced morphological changes in HK-2 cells. Additionally, SGS reduced the expression of Akt and p38 while upregulating PI3K and Erk1/2 in NaOX-treated HK-2 cells. These results suggested that SGS enhances wound healing and regulates the expression of adhesion molecules, possibly through the PI3K/Akt and MAPK (p38 and Erk1/2) signaling pathways, highlighting the potential of SGS as a promising therapeutic compound for preventing and treating NaOX-induced renal damage.</p>
</abstract>
<kwd-group>
<kwd>sulfation of sulfated galactan</kwd>
<kwd>cell migration</kwd>
<kwd>adhesion molecules</kwd>
<kwd>human kidney cells</kwd>
<kwd>sodium oxalate</kwd>
</kwd-group>
<funding-group>
<funding-statement><bold>Funding:</bold> The present study was supported by the Faculty of Medicine, Khon Kaen University, Thailand (grant no. IN63318), Research and Graduate Studies, Khon Kaen University (grant no. RP65-2-002) and Postgraduate Study Support Grant of the Faculty of Medicine, Khon Kaen University (grant no. 647070001-4).</funding-statement>
</funding-group>
</article-meta>
</front>
<body>
<sec sec-type="intro">
<title>Introduction</title>
<p>Urolithiasis, or kidney stone formation, is one of the most common urological conditions and is characterized by the deposition of crystals or stones within the kidneys (<xref rid="b1-BR-23-2-02001" ref-type="bibr">1</xref>). Calcium oxalate (CaOX) and/or calcium phosphate are the predominant types of renal stones and their formation is closely associated with increased production of reactive oxygen species (ROS) (<xref rid="b2-BR-23-2-02001" ref-type="bibr">2</xref>). The key processes underlying stone formation are influenced by multiple factors, including elevated urinary calcium and phosphate levels, as well as the relationship between urinary volume and CaOX crystal formation (<xref rid="b3-BR-23-2-02001" ref-type="bibr">3</xref>). Renal calculi in urolithiasis may also result from increased glycolic acid oxidase activity induced by sodium oxalate (NaOX), which generates glycolate and oxalate (<xref rid="b2-BR-23-2-02001" ref-type="bibr">2</xref>). When oxalate crystals deposit and adhere to renal tubular epithelial cells, these cells become injured and impaired (<xref rid="b4-BR-23-2-02001" ref-type="bibr">4</xref>). In response to renal injury, epithelial cells initiate proliferation and migration to promote regeneration and tissue repair. Collective cell migration is a tightly regulated process essential for normal physiological activities, including tissue repair and wound healing (<xref rid="b5-BR-23-2-02001" ref-type="bibr">5</xref>). Among the key molecules involved in cell migration and polarization are E-cadherin and vimentin, which play critical roles in regulating these processes. E-cadherin is a key integral protein that mediates lateral cell-to-cell adhesion via adherens junctions, playing a crucial role in maintaining tissue integrity and inhibiting relative cell mobility. By contrast, vimentin functions as a critical regulator of the wound repair process, serving as an intermediate filament that facilitates cell motility and migration (<xref rid="b6-BR-23-2-02001" ref-type="bibr">6</xref>). Epithelial tight junction proteins, such as zonula occludens (ZOs), occludin, claudins and junctional adhesion molecules, are also essential for regulating paracellular transport in renal tubular epithelial cells (<xref rid="b7-BR-23-2-02001" ref-type="bibr">7</xref>). These proteins can be altered following renal stone-induced damage. For example, treatment of Madin-Darby canine kidney (MDCK) cells with calcium oxalate monohydrate (COM) crystals has been shown to impair tight junction function by reducing the expression of occludin and ZO-1(<xref rid="b8-BR-23-2-02001" ref-type="bibr">8</xref>). Similarly, treatment of rat renal tubular epithelial cells (NRK-52E) with COM crystals induces changes in adhesion molecules, including hyaluronic acid, osteopontin and CD44(<xref rid="b9-BR-23-2-02001" ref-type="bibr">9</xref>). Thus, alterations in cellular signaling and adhesion molecules in renal tubular epithelial cells are critical determinants of oxalate crystal-induced injury and tissue repair (<xref rid="b10-BR-23-2-02001" ref-type="bibr">10</xref>). Understanding these changes may provide insights into potential therapeutic approaches for diseases related to oxalate crystal deposition.</p>
<p>Currently, there is no specific drug that effectively treats or prevents urolithiasis, despite numerous biological and physical studies aimed at preventing its development (<xref rid="b2-BR-23-2-02001" ref-type="bibr">2</xref>). However, a number of researchers have turned to natural medicinal agents to evaluate their anti-urolithiasis potential (<xref rid="b11-BR-23-2-02001" ref-type="bibr">11</xref>,<xref rid="b12-BR-23-2-02001" ref-type="bibr">12</xref>). The increasing interest in medicinal herbs can be attributed to their wide-spread availability, low cost, long history of traditional use and minimal side effects.</p>
<p><italic>Gracilaria fisheri</italic> is a common red seaweed widely found along the coastal areas of Thailand. It is rich in sulfated galactan (SG), which primarily consists of repeating units of D-galactose and 3,6-anhydrogalactose with sulfate residues (<xref rid="b13-BR-23-2-02001" ref-type="bibr">13</xref>). SG is known for its various biological activities, including immunostimulant (<xref rid="b13-BR-23-2-02001" ref-type="bibr">13</xref>), antioxidant (<xref rid="b14-BR-23-2-02001" ref-type="bibr">14</xref>) and wound healing properties (<xref rid="b15-BR-23-2-02001" ref-type="bibr">15</xref>). Our previous study demonstrated that modifying SG to increase its sulfation, resulting in sulfated galactan from <italic>G. fisheri</italic> (SGS), inhibited oxalate crystal formation and provided enhanced protection against NaOX-induced human kidney (HK-2) cell death (<xref rid="b16-BR-23-2-02001" ref-type="bibr">16</xref>). It is considered that certain moieties of the polysulfated chain of SGS can serve as mimetics of natural ligand-protein receptor-glycosaminoglycans, which interact with various proteins, leading to post-translational modifications and modulation of signaling molecules inside the cells (<xref rid="b17-BR-23-2-02001" ref-type="bibr">17</xref>). These modifications determine cell behavior and responses (<xref rid="b18-BR-23-2-02001" ref-type="bibr">18</xref>). As previously reported, SG from <italic>G. fisheri</italic> has been demonstrated to interact with the epidermal growth factor receptor (EGFR), resulting in the regulation of EGFR signaling activity, including p-EGFR and p-Erk levels (<xref rid="b19-BR-23-2-02001" ref-type="bibr">19</xref>). In addition, studies have also revealed that the expression of adhesion molecules, such as EpCAM, is regulated by EGFR signaling (<xref rid="b20-BR-23-2-02001" ref-type="bibr">20</xref>,<xref rid="b21-BR-23-2-02001" ref-type="bibr">21</xref>). Accumulating evidence suggests that SGS may modulate cell signaling pathways and upregulate the expression of cell adhesion molecules, potentially facilitating cell migration and tissue repair. It was hypothesized that SGS promotes cell migration, regulates the expression of adhesion molecules and downstream signaling pathways in HK-2 cells and provides a protective effect against oxalate crystal-induced injury. In addition, the effects of SGS on wound healing and the expression of adhesion molecules in NaOX-induced HK-2 cell injury have not yet been investigated. The present study aimed to evaluate the effects of SGS on cell migration and adhesion molecule expression in NaOX-induced HK-2 cell injury. HK-2 cell migration was assessed using scratch migration and Transwell assays. The mRNA and protein expression levels of adhesion molecules were analyzed using reverse transcription-quantitative (RT-q) PCR, western blotting and immunofluorescence confocal microscopy under NaOX-induced conditions. Additionally, the morphology of HK-2 cells treated with SGS and NaOX was examined using scanning electron microscopy. The present study, for the first time to the best of the authors&#x0027; knowledge, explored the effects of SGS on cell migration, the expression of cell adhesion molecules and cell signaling pathways under NaOX-induced conditions. These findings are expected to provide evidence supporting the potential use of SGS in the prevention and treatment of urolithiasis and related renal injuries.</p>
</sec>
<sec sec-type="Materials|methods">
<title>Materials and methods</title>
<sec>
<title/>
<sec>
<title>Materials, chemicals and reagents</title>
<p>SGS was prepared as described by Rudtanatip <italic>et al</italic> (<xref rid="b15-BR-23-2-02001" ref-type="bibr">15</xref>). SGS, with a molecular weight of 97.07 kDa and a sulfation level of 26.53&#x00B1;1.09&#x0025;, consists of a complex structure of alternating 3-linked &#x03B2;-D-galactopyranose and 4-linked 3,6-anhydro-&#x03B1;-L-galactopyranose or &#x03B1;-L-galactopyranose, containing sulfate groups at C-2, C-4 and C-6 of D-galactopyranose, C-2 of L-anhydro-galactopyranose and C-2 and C-6 of L-galactopyranose. The backbone structure of SGS is shown in <xref rid="f1-BR-23-2-02001" ref-type="fig">Fig. 1</xref>. The human kidney cell line (HK-2) was purchased from ATCC. Dulbecco&#x0027;s Modified Eagle&#x0027;s Medium (DMEM), fetal bovine serum (FBS) and Anti-Anti (100X) antibiotic-antimycotic were obtained from Thermo Fisher Scientific, Inc. Cystone was procured from the Himalaya Wellness Company. Transwell permeable supports (6.5 mm inserts, 24-well plates) were purchased from Corning Life Sciences. TRIzol<sup>&#x00AE;</sup> reagent and the RevertAid First Strand cDNA Synthesis Kit were obtained from Thermo Fisher Scientific, Inc. PowerUp SYBR&#x2122; Green Master Mix was purchased from Applied Biosystems (Thermo Fisher Scientific, Inc.). The Protease Inhibitor Cocktail (100X) was procured from MedChemExpress. Nitrocellulose membrane was purchased from Global Life Science Operations. Clarity Western ECL substrate was obtained from Bio-Rad Laboratories, Inc. CellMask Deep Red Plasma Membrane Stain was purchased from Thermo Fisher Scientific, Inc. All other chemicals were purchased from Merck KGaA.</p>
</sec>
<sec>
<title>HK-2 cell culture and experimental design</title>
<p>HK-2 cells were cultured in DMEM supplemented with 2.2 g/l sodium bicarbonate, 10&#x0025; FBS and 1&#x0025; antibiotic-antimycotic in a humidified incubator at 37&#x02DA;C with 5&#x0025; CO<sub>2</sub>. To evaluate the effects of SGS on NaOX-induced injury in HK-2 cells, 1.25 mmol/l of NaOX was used for induction, as described in our previous study (<xref rid="b16-BR-23-2-02001" ref-type="bibr">16</xref>). The cytotoxicity of NaOX on HK-2 cells was observed at the concentrations ranging from 0.156-5.0 mmol/l, with NaOX showing a dose-dependent reduction in cell proliferation. This concentration (1.25 mmol/l) decreased cell viability by &#x003C;50&#x0025; (<xref rid="b16-BR-23-2-02001" ref-type="bibr">16</xref>). The cells were divided into 5 groups: i) Control-no treatment; ii) NaOX control-treated with 1.25 mmol/l of NaOX; iii) 100-SGS + NaOX-treated with 100 &#x00B5;g/ml of SGS combined with 1.25 mmol/l of NaOX; iv) 1000-SGS + NaOX-treated with 1,000 &#x00B5;g/ml of SGS combined with 1.25 mmol/l of NaOX; v) Cystone + NaOX-treated with 100 &#x00B5;g/ml of Cystone, a positive control drug, combined with 1.25 mmol/l of NaOX. Cystone was used as a positive control because it is commonly used to relieve urological problems, including nephrolithiasis (<xref rid="b22-BR-23-2-02001" ref-type="bibr">22</xref>). It has also been employed as a positive control in numerous experimental studies evaluating its anti-urolithiasis activity, both <italic>in vitro</italic> and <italic>in vivo</italic> (<xref rid="b23-BR-23-2-02001" ref-type="bibr">23</xref>,<xref rid="b24-BR-23-2-02001" ref-type="bibr">24</xref>). Prior to treatment with NaOX and SGS, the cells were incubated overnight in a serum-free culture medium to achieve synchronization.</p>
</sec>
<sec>
<title>Scratch wound healing assay</title>
<p>The rate of HK-2 cell migration was assessed using a scratch wound healing assay. Cells were seeded in 24-well plates at a density of 4.5x10<sup>4</sup> cells/well in DMEM supplemented with 10&#x0025; FBS. Once the cells reached 80-100&#x0025; confluence, they were incubated overnight in a serum-free culture medium and a scratch was created on the bottom of the well using a 200-&#x00B5;l sterile pipette tip. Detached cells were removed by washing twice with 1X PBS. The remaining cells were treated with either the SGS mixed NaOX solution or the Cystone mixed NaOX solution. Cell migration was monitored and imaged at 0, 6, 12 and 24 h post-treatment using a Nikon Eclipse TS100 inverted microscope (Nikon Corporation). The average distance between the edges of the scratch was calculated to determine the wound width.</p>
</sec>
<sec>
<title>Transwell cell migration assay</title>
<p>To evaluate cell migration, HK-2 cells were seeded into the upper chamber of a 24-well HTS Transwell Permeable Supports plate at a density of 4.5x10<sup>4</sup> cells/well in serum-free DMEM. The cells were treated with either the SGS mixed NaOX solution or the Cystone mixed NaOX solution, while DMEM supplemented with 10&#x0025; FBS was added to the lower chamber as a chemoattractant. After 24 h, the migrated cells in the lower chamber were fixed with 10&#x0025; neutral buffered formalin at room temperature for 20 min, stained with toluidine blue O at room temperature for 10 min and visualized under an inverted microscope (Leica Biosystems).</p>
</sec>
<sec>
<title>Analysis of adhesion mRNA transcription by quantitative polymerase chain reaction (qPCR) assay</title>
<p>HK-2 cells were seeded in a 6-well plate at a density of 1.6x10<sup>5</sup> cells/well in DMEM supplemented with 10&#x0025; FBS and cultured at 37&#x02DA;C for 24 h. The cells were then treated with either the SGS mixed NaOX solution or the Cystone mixed NaOX solution and incubated for an additional 24 h. Following treatment, the cells were harvested for RNA extraction. Total RNA was extracted using the TRIzol<sup>&#x00AE;</sup> reagent (Thermo Fisher Scientific, Inc.) and cDNA was synthesized using the RevertAid First Strand cDNA Synthesis Kit (Thermo Fisher Scientific, Inc.), following the manufacturer&#x0027;s instructions. mRNA expression of CD44, EpCAM, E-cadherin, vimentin, occludin, ZO-1 and GAPDH was analyzed by qPCR using PowerUp SYBR Green Master Mix (Applied Biosystems; Thermo Fisher Scientific, Inc.), as per the manufacturer&#x0027;s protocol. The specific primer sequences used in the experiment are listed in <xref rid="tI-BR-23-2-02001" ref-type="table">Table I</xref>. Each 20-&#x00B5;l PCR reaction mixture contained 10 &#x00B5;l of PowerUp SYBR Green Master Mix, 0.8 &#x00B5;l of 500 nM forward and reverse primers, 7.2 &#x00B5;l of nuclease-free water and 2 &#x00B5;l of cDNA. The cycling conditions were as follows: 50&#x02DA;C for 2 min, 95&#x02DA;C for 10 min, followed by 40 cycles of 95&#x02DA;C for 15 sec, 60&#x02DA;C for 30 sec and 72&#x02DA;C for 30 sec. Amplification and analysis were performed using the QuantStudio 6 Flex Real-Time PCR System (Applied Biosystems; Thermo Fisher Scientific, Inc.). GAPDH was used as the housekeeping gene for normalization and relative gene expression was calculated using the 2<sup>-&#x2206;&#x2206;Cq</sup> method (<xref rid="b25-BR-23-2-02001" ref-type="bibr">25</xref>). The experiments were performed in triplicate.</p>
</sec>
<sec>
<title>Determination of adhesion molecule and signaling protein expression by western blot assay</title>
<p>HK-2 cells were harvested after treatment and used for protein extraction in a protein lysis buffer containing 20 mM Tris-HCl, 100 mM NaCl, 50 mM PMSF and 1X protease inhibitor cocktail. Total protein extracts were quantified using a NanoDrop 2000 spectrophotometer (Thermo Fisher Scientific, Inc.) to determine protein concentration. The protein samples (50 &#x00B5;g/lane) were then separated on a 12.5&#x0025; SDS-PAGE gel and transferred onto a nitrocellulose membrane. The membrane was blocked with 4&#x0025; bovine serum albumin (BSA; Merck KGaA) in 1X Tris-buffered saline at room temperature for 2 h and then incubated overnight at 4&#x02DA;C with primary antibodies specific to CD44, EpCAM, E-cadherin, vimentin, occludin, ZO-1, PI3K, Akt, Erk1/2 and p38 (1:1,000 dilution). Subsequently, the membrane was incubated at room temperature for 1 h with a secondary antibody: HRP-conjugated goat anti-rabbit IgG (1:2,000 dilution) for CD44, EpCAM, occludin, ZO-1, PI3K, Akt, Erk1/2 and p38, or HRP-conjugated goat anti-mouse IgG (1:2,000 dilution) for E-cadherin and vimentin. The antibodies used in the experiment are listed in <xref rid="tII-BR-23-2-02001" ref-type="table">Table II</xref>. The protein signals were developed using a Clarity Western ECL substrate (Bio-Rad Laboratories, Inc.) and band intensities were analyzed relative to the internal control (&#x03B2;-actin) using ImageJ version 1.32j (National Institutes of Health).</p>
</sec>
<sec>
<title>Immunofluorescence confocal microscopy</title>
<p>HK-2 cells were seeded onto round glass coverslips in a 24-well plate at a density of 4.5x10<sup>4</sup> cells/well in DMEM supplemented with 10&#x0025; FBS and cultured at 37&#x02DA;C for 24 h. The cells were then treated with either the SGS mixed NaOX solution or the Cystone mixed NaOX solution and allowed to grow for an additional 24 h before being fixed with 10&#x0025; formalin at room temperature for 20 min. The fixed cells were washed three times with 1X PBS and incubated overnight with primary antibodies specific to CD44, E-cadherin, vimentin, EpCAM, occludin and ZO-1 (1:250 dilution), as shown in <xref rid="tII-BR-23-2-02001" ref-type="table">Table II</xref>. They were then incubated at room temperature for 1 h with FITC-conjugated goat anti-rabbit IgG (1:500 dilution) for CD44, EpCAM, occludin and ZO-1, or FITC-conjugated goat anti-mouse IgG (1:500 dilution) for E-cadherin and vimentin. Finally, the cells were stained at room temperature for 20 min with DAPI for nuclear visualization and CellMask Deep Red Plasma Membrane Stain to label the cytoplasm and plasma membranes, following the manufacturer&#x0027;s protocols. Images were captured using a Zeiss LSM800 inverted confocal laser scanning microscope (Carl Zeiss AG) equipped with a 63x Plan-Apochromat 1.4 NA oil immersion objective lens (magnification, x630). Laser wavelengths and pinhole size were set as follows: 488 nm with a 43 &#x00B5;m pinhole for FITC staining, 405 nm with a 42 &#x00B5;m pinhole for DAPI staining and 561 nm with a 53 &#x00B5;m pinhole for CellMask Deep Red Plasma Membrane staining.</p>
</sec>
<sec>
<title>Observation of cell morphology by scanning electron microscopy</title>
<p>HK-2 cells were seeded onto round glass coverslips in a 24-well plate at a density of 4.5x10<sup>4</sup> cells/well in DMEM supplemented with 10&#x0025; FBS and cultured at 37&#x02DA;C for 24 h. The cells were then treated with either the SGS mixed NaOX solution or the Cystone mixed NaOX solution and allowed to grow for an additional 24 h. Following incubation, the cells were fixed with 2.5&#x0025; glutaraldehyde at room temperature for 30 min. The coverslips were then washed with 1X PBS, dehydrated and air-dried overnight. The dried coverslips were mounted onto aluminum stubs and coated with gold particles. Cell morphology was subsequently examined using a JSM-IT200 InTouchScope scanning electron microscope (JEOL, Ltd.).</p>
</sec>
<sec>
<title>Statistical analysis</title>
<p>All data were expressed as mean &#x00B1; SEM from three independent experiments. Statistical analysis was performed using one-way ANOVA, followed by Tukey&#x0027;s multiple comparison test using GraphPad Prism version 9 (Dotmatics). P&#x003C;0.05 was considered to indicate a statistically significant difference.</p>
</sec>
</sec>
</sec>
<sec sec-type="Results">
<title>Results</title>
<sec>
<title/>
<sec>
<title>Gracilaria fisheri sulfated galactan with increased sulfation (SGS) enhances HK-2 cell migration, counteracting NaOX-induced inhibition of cell migration</title>
<p>The present study investigated the effect of SGS on cell migration using a scratch wound assay. The initial wound edges were marked to measure cell migration by tracking the decrease in wound width over time. The scratch distances between wound edges were compared across time points (0, 6, 12 and 24 h). The results showed no significant differences in wound gape among the groups at 0 and 6 h after scratching. However, at 12 and 24 h after scratching, the wound gape in the NaOX group was markedly larger compared with the normal control group. Notably, a significant reduction in wound gape was observed at 12 h in NaOX-induced HK-2 cells treated with SGS (1,000 &#x00B5;g/ml) compared with the NaOX group. By 24 h, NaOX-induced HK-2 cells treated with SGS (100 and 1,000 &#x00B5;g/ml) and Cystone showed a significant decrease in wound gape compared with the NaOX group (<xref rid="f2-BR-23-2-02001" ref-type="fig">Fig. 2A</xref> and <xref rid="f1-BR-23-2-02001" ref-type="fig">B</xref>). To further confirm the cell migration promoting ability of SGS, a Transwell plate assay was performed. As shown in <xref rid="f3-BR-23-2-02001" ref-type="fig">Fig. 3</xref>, NaOX treatment reduced the number of migratory HK-2 cells compared with the control. However, treatment with SGS (100 and 1,000 &#x00B5;g/ml) and Cystone markedly increased the number of migratory cells in NaOX-induced HK-2 cells. These results suggest that SGS markedly enhances HK-2 cell migration at the wound edge and promotes cell migration in NaOX-induced HK-2 cells.</p>
</sec>
<sec>
<title>SGS positively regulates the expression of adhesion molecules in HK-2 cells induced by NaOX</title>
<p>Cell adhesion molecules play a critical role in maintaining cell polarity, integrity and function (<xref rid="b7-BR-23-2-02001" ref-type="bibr">7</xref>). To evaluate the effects of SGS on the expression of adhesion molecules in NaOX-induced HK-2 cell damage, qPCR and western blot analyses were conducted to detect the expression levels of CD44, EpCAM, E-cadherin, vimentin, occludin and ZO-1. The qPCR results showed significant alterations in mRNA expression in HK-2 cells treated with NaOX, SGS + NaOX and Cystone + NaOX. Specifically, the expression levels of EpCAM, E-cadherin, occludin and ZO-1 were markedly downregulated following NaOX exposure, while CD44 and vimentin were markedly upregulated. Treatment with SGS (1,000 &#x00B5;g/ml) markedly upregulated the expression levels of CD44, EpCAM, E-cadherin and occludin and markedly downregulated the expression of vimentin, compared with the NaOX control. However, no significant changes in ZO-1 expression were observed. Similarly, the expression levels of adhesion molecule mRNA in NaOX-induced HK-2 cells treated with Cystone (positive control) were consistent with those in SGS-treated cells (<xref rid="f4-BR-23-2-02001" ref-type="fig">Fig. 4</xref>). Western blotting results (<xref rid="f5-BR-23-2-02001" ref-type="fig">Fig. 5</xref>) further corroborated the qPCR findings. In NaOX-induced HK-2 cell damage, the protein expression levels of adhesion molecules followed a similar trend. Following treatment with SGS, the protein expression levels of CD44 and vimentin were markedly downregulated, while the expression levels of EpCAM, E-cadherin, occludin and ZO-1 were markedly upregulated, compared with the NaOX control. These results suggested that SGS can modulate the expression of adhesion molecules at both the mRNA and protein levels, providing protective effects against NaOX-induced damage in HK-2 cells.</p>
<p>Additionally, confocal immunofluorescence staining was performed to confirm the distribution of adhesion molecules in HK-2 cells. The results showed that NaOX-induced HK-2 cells exhibited increased expression of CD44 and vimentin, while the expression of EpCAM, E-cadherin, occludin and ZO-1 was decreased (<xref rid="f6-BR-23-2-02001" ref-type="fig">Fig. 6</xref>). By contrast, HK-2 cells treated with SGS + NaOX showed decreased expression of CD44 and vimentin, alongside increased expression of EpCAM, E-cadherin, occludin and ZO-1. These findings indicate that NaOX alters the expression patterns of adhesion molecules, while SGS mitigates NaOX-induced toxicity and restores adhesion molecule expression to a more normal state.</p>
</sec>
<sec>
<title>NaOX-induces morphological changes of HK-2 cells were reversed by SGS</title>
<p>The effect of SGS on the morphological changes of NaOX-induced HK-2 cells was examined using scanning electron microscopy, as shown in <xref rid="f7-BR-23-2-02001" ref-type="fig">Fig. 7</xref>. Normal HK-2 cells (control) exhibited thick, long, slender and regular cytoplasmic processes that were tightly interconnected with the cytoplasmic processes of neighboring cells. By contrast, NaOX-induced HK-2 cell damage resulted in significant morphological alterations, including cell volume retraction and the presence of very thin, long, slender and irregular cytoplasmic processes. However, NaOX-induced HK-2 cells treated with SGS displayed thin, long, slender and regular cytoplasmic processes, resembling those observed in the control and Cystone-treated cells. These findings suggested that SGS exerts a cell recovery effect, mitigating the morphological damage caused by NaOX in HK-2 cells.</p>
</sec>
<sec>
<title>SGS alters the expression of PI3K, Akt, Erk1/2 and p38 signaling proteins in NaOX-induced HK-2 cell damage</title>
<p>The PI3K/Akt and MAPK signaling pathways play a critical role in regulating various cellular processes, including the cell cycle, survival and death. These pathways are closely associated with the pathological mechanisms of kidney diseases (<xref rid="b26-BR-23-2-02001" ref-type="bibr">26</xref>). To evaluate the effects of SGS on signaling pathways, we investigated the expression of key signaling proteins, including PI3K, Akt, Erk1/2 and p38, in NaOX-induced HK-2 cell damage. As shown in <xref rid="f8-BR-23-2-02001" ref-type="fig">Fig. 8</xref>, NaOX exposure markedly upregulated the expression levels of Akt and p38, while downregulating the expression levels of PI3K and Erk1/2. However, treatment of NaOX-induced HK-2 cells with SGS markedly reversed these changes. Specifically, SGS treatment (1,000 &#x00B5;g/ml) markedly upregulated the expression levels of PI3K and Erk1/2 while downregulating the expression levels of Akt and p38, compared with the NaOX control. These effects were consistent with those observed in Cystone-treated NaOX-induced HK-2 cells.</p>
</sec>
</sec>
</sec>
<sec sec-type="Discussion">
<title>Discussion</title>
<p>Biological activities of sulfated polysaccharides are strongly influenced by their molecular structures, including molecular weight and degree of sulfation (<xref rid="b27-BR-23-2-02001" ref-type="bibr">27</xref>). The present study demonstrated that SGS enhanced cell migration ability and wound healing activity in NaOX-induced HK-2 cells. Kidney stone (oxalate crystal) formation has been linked to increased glycolic acid oxidase activity induced by NaOX, leading to injury and impairment of renal tubular epithelial cells (<xref rid="b2-BR-23-2-02001" ref-type="bibr">2</xref>,<xref rid="b28-BR-23-2-02001" ref-type="bibr">28</xref>). In response to injury, renal tubular epithelial cells compensate through proliferation and migration to promote tissue repair (<xref rid="b5-BR-23-2-02001" ref-type="bibr">5</xref>). However, NaOX inhibits renal epithelial cell migration, potentially exacerbating kidney disease progression, as observed in MDCK cells exposed to NaOX (<xref rid="b29-BR-23-2-02001" ref-type="bibr">29</xref>). In the present study, SGS markedly enhanced wound healing activity in HK-2 cells, which aligns with previous findings showing that SGS promoted wound closure in an L929 fibroblast scratch model (<xref rid="b15-BR-23-2-02001" ref-type="bibr">15</xref>). This suggests that increased sulfation of polysaccharides is closely associated with enhanced wound healing properties (<xref rid="b15-BR-23-2-02001" ref-type="bibr">15</xref>).</p>
<p>Cell adhesion molecules play a crucial role in the processes of tissue injury and repair (<xref rid="b30-BR-23-2-02001" ref-type="bibr">30</xref>). Dysregulation of these molecules is also critical in triggering signaling cascades that can lead to apoptotic or necrotic cell death. The detachment of injured cells is linked to changes in adhesion molecules such as cadherins, integrins and occludin junction proteins, which are essential for maintaining cell-cell and cell-extracellular matrix adhesions (<xref rid="b31-BR-23-2-02001" ref-type="bibr">31</xref>). Oxalate crystals interact with renal epithelial cells, altering tight junctions by decreasing the expression levels of key proteins such as ZO-1, occludin and claudin (<xref rid="b32-BR-23-2-02001" ref-type="bibr">32</xref>). Additionally, oxalate crystals promote renal epithelial cell damage by upregulating adhesion proteins, including hyaluronic acid, osteopontin, CD44 and annexin A2, on the cell surface (<xref rid="b9-BR-23-2-02001" ref-type="bibr">9</xref>). Conversely, oxalate crystal deposition in the kidneys of hyperoxaluric rats is reduced when osteopontin expression is inhibited, highlighting its role in crystal formation and retention (<xref rid="b33-BR-23-2-02001" ref-type="bibr">33</xref>). Additionally, E-cadherin and vimentin are key proteins involved in regulating cell migration and polarization. E-cadherin, an integral membrane protein, mediates lateral cell-to-cell adhesion through adherens junctions, playing a critical role in maintaining tissue integrity and inhibiting cell mobility. By contrast, vimentin serves as an intermediate filament that regulates the wound repair process by promoting cell motility and migration (<xref rid="b6-BR-23-2-02001" ref-type="bibr">6</xref>). The inhibition of MDCK cell migration by oxalate crystals, as reported by Ji <italic>et al</italic> (<xref rid="b29-BR-23-2-02001" ref-type="bibr">29</xref>), may be linked to the dysregulation of E-cadherin and vimentin. In the present study, NaOX exposure altered the expression of CD44, EpCAM, E-cadherin, vimentin, occludin and ZO-1 in HK-2 cells, suggesting damage to barrier function, loss of cell adhesion and impaired cell migration. Additionally, increased expression of CD44 has been shown to upregulate cytoskeleton function through ankyrin, activating the actomyosin contractile complex to mediate cell migration (<xref rid="b34-BR-23-2-02001" ref-type="bibr">34</xref>) and may directly affect wound healing (<xref rid="b35-BR-23-2-02001" ref-type="bibr">35</xref>). The increased expression of CD44 induced by NaOX in the present study may reflect a compensatory cellular response by enhancing contraction, migration and wound healing. Another possible reason for the increased CD44 expression under NaOX-induced conditions is an imbalance between cellular oxidants and antioxidants, leading to the expression of inflammatory molecules (<xref rid="b36-BR-23-2-02001" ref-type="bibr">36</xref>).</p>
<p>However, SGS treatment alleviated the effects of NaOX by restoring the expression levels of these molecules to near-normal levels. Several studies further support the protective effects of compounds on the expression of proteins and RNA involved in cell adhesion and migration, which mitigate kidney injury. For example, downregulation of osteopontin by caffeic acid inhibited kidney stone formation (<xref rid="b37-BR-23-2-02001" ref-type="bibr">37</xref>). In a glyoxylate-induced nephrolithiasis mouse model, curcumin administration reduced calcium oxalate crystal deposition and renal tissue damage by decreasing the expression of osteopontin and CD44(<xref rid="b38-BR-23-2-02001" ref-type="bibr">38</xref>). Similarly, treatment of MDCK cells with the plant alkaloid trigonelline attenuated oxalate-induced epithelial-to-mesenchymal transition by increasing the expression of epithelial markers E-cadherin and ZO-1(<xref rid="b39-BR-23-2-02001" ref-type="bibr">39</xref>).</p>
<p>Oxalate crystals not only alter the transcription and translation of adhesion molecules but also markedly alter cell morphology. Renal cells exposed to oxalate crystals exhibit distinct morphological changes, including structural disorganization, cell edema, chromatin condensation, translocation of phosphatidylserine to the cell surface and displacement of membrane proteins (<xref rid="b40-BR-23-2-02001" ref-type="bibr">40</xref>,<xref rid="b23-BR-23-2-02001" ref-type="bibr">23</xref>). These morphological changes are closely linked to and functionally integrated with the actin-based cytoskeleton (<xref rid="b41-BR-23-2-02001" ref-type="bibr">41</xref>). In the present study, NaOX exposure induced marked morphological changes in HK-2 cells, as observed under scanning electron microscopy. However, treatment with SGS restored the morphology of oxalate-injured cells, which gradually returned to a normal appearance. These findings align with a previous study demonstrating the cytoprotective effects of <italic>D. pedicellata</italic> ethanolic extract and Cystone in oxalate crystal-induced cell damage, where restoration of cell morphology was also observed (<xref rid="b23-BR-23-2-02001" ref-type="bibr">23</xref>).</p>
<p>The mechanisms underlying kidney injury caused by oxalate crystals are multifactorial and complex, with a number of aspects that remain to be elucidated. The PI3K/Akt and MAPK signaling pathways are closely linked to the pathological processes of kidney diseases and play crucial roles in cellular functions, including the cell cycle, survival and tissue repair (<xref rid="b26-BR-23-2-02001" ref-type="bibr">26</xref>,<xref rid="b42-BR-23-2-02001" ref-type="bibr">42</xref>). The findings of the present study revealed that NaOX exposure increased the expression of Akt and p38 while decreasing the expression of PI3K and Erk1/2. Conversely, SGS treatment reversed these effects, increasing the expression of PI3K and Erk1/2 and reducing the expression of Akt and p38, highlighting the possible protective effects of SGS against NaOX-induced damage. The potential mechanisms by which SGS modulates Akt, p38, PI3K and Erk1/2 in NaOX-induced cell death may involve its high sulfate ester content, which imparts a strong negative charge, enabling binding to cell surface receptors and regulation of the PI3K/Akt/MAPK pathways (<xref rid="b43-BR-23-2-02001" ref-type="bibr">43</xref>,<xref rid="b44-BR-23-2-02001" ref-type="bibr">44</xref>). Additionally, SGS interferes with crystal formation, reducing crystal-cell binding and subsequently inhibiting reactive oxygen species (ROS) production, which contributes to tight junction alteration via regulation of the ROS/Akt/p38 MAPK signaling pathway (<xref rid="b8-BR-23-2-02001" ref-type="bibr">8</xref>). The antioxidant properties of SGS may also neutralize NaOX-induced free radicals, thereby suppressing oxidative stress and modulating downstream signaling molecules (<xref rid="b16-BR-23-2-02001" ref-type="bibr">16</xref>). However, the protective effect of SGS against NaOX-induced damage in HK-2 cells requires further confirmation using PI3K/Akt and MAPK signaling inhibitors.</p>
<p>Oxalate crystal induction is associated with increased cell death and dysregulation of the PI3K/Akt and MAPK signaling pathways. Consistent with this, treating MDCK cells with oxalate crystals has been shown to reduce the expression of junctional proteins, such as ZO-1 and occludin, while increasing the expression of Akt/ASK1/p38 MAPK signaling proteins (<xref rid="b8-BR-23-2-02001" ref-type="bibr">8</xref>). Transcriptomic analysis of renal tubular epithelial cells and mouse kidneys exposed to oxalate crystals has revealed that kidney stone formation is associated with activation of the PI3K/Akt signaling pathway (<xref rid="b45-BR-23-2-02001" ref-type="bibr">45</xref>). Additionally, p38 MAPK has been implicated in oxalate crystal-induced tight junction alteration in rat renal tubular epithelial (NRK-52E) cells. The mRNA and protein expression levels of p38 MAPK-related molecules &#x005B;such as phosphorylated (p-)p38&#x005D; and adhesion molecules (such as osteopontin, hyaluronic acid and CD44) were markedly increased in NRK-52E cells treated with oxalate crystals (<xref rid="b9-BR-23-2-02001" ref-type="bibr">9</xref>,<xref rid="b32-BR-23-2-02001" ref-type="bibr">32</xref>). These findings are consistent with the present study, which showed that NaOX increased the expression of Akt and p38 while decreasing the expression of PI3K and Erk1/2. This response may reflect cellular compensation and repair mechanisms in response to oxalate crystal-induced ROS generation and cell injury (<xref rid="b46-BR-23-2-02001" ref-type="bibr">46</xref>,<xref rid="b47-BR-23-2-02001" ref-type="bibr">47</xref>). In addition, the decreased expression of Erk1/2 by NaOX may be attributed to increased ROS generation through the inhibition of the AMPK/mTOR/ERK signaling axis (<xref rid="b48-BR-23-2-02001" ref-type="bibr">48</xref>).</p>
<p>SGS treatment demonstrated opposing effects on the expression levels of PI3K, Akt, p38 and Erk1/2, effectively alleviating the effect of NaOX by restoring these signaling molecules to near-normal levels. Inhibition of p38 MAPK has been shown to reduce oxalate crystal-induced cell adhesion and injury. For example, treatment with SB239063, a p38 MAPK inhibitor, decreases p38 expression and inhibits oxalate crystal adhesion and cell damage in NRK-52E cells (<xref rid="b9-BR-23-2-02001" ref-type="bibr">9</xref>). Similarly, quercetin, a molecule with potent antioxidant and anti-inflammatory effects, suppresses p38 MAPK activation, mitigating oxidative stress and reducing oxalate crystal-induced injury in HK-2 cells (<xref rid="b49-BR-23-2-02001" ref-type="bibr">49</xref>). These findings are consistent with the results of the present study, in which SGS decreased the expression of p38 in NaOX-induced HK-2 cell injury. By contrast, Puerarin, an isoflavone derived from the root of <italic>Pueraria lobata</italic>, has been reported to activate the SIRT1/Akt/p38 signaling pathways, thereby reducing oxalate crystal-induced oxidative stress and autophagy, suggesting its potential to directly inhibit autophagy activation (<xref rid="b50-BR-23-2-02001" ref-type="bibr">50</xref>). Similarly, it can be implied that SGS suppressed Akt and p38 activation, mitigating ROS generation and reducing HK-2 cell death induced by NaOX. The observed increase in PI3K and Erk1/2 expression following SGS treatment may be related to the migration of non-injured epithelial cells adjacent to the site of injury, promoting wound healing activity (<xref rid="b46-BR-23-2-02001" ref-type="bibr">46</xref>). PI3K/Akt activation mediates VEGF-driven cell survival (<xref rid="b47-BR-23-2-02001" ref-type="bibr">47</xref>), while Erk1/2 signaling regulates cell migration and proliferation during wound healing. Specifically, inhibition of Erk1/2 delays wound healing, whereas its activation stimulates cell migration and proliferation (<xref rid="b51-BR-23-2-02001" ref-type="bibr">51</xref>). Two effects of SGS on NaOX-induced cell death can be proposed: i) SGS inhibits NaOX-induced cell death by suppressing ROS production mediated by Akt and p38 and ii) SGS promotes cell migration by activating PI3K and Erk1/2, thereby enhancing wound healing. These findings suggested that SGS may contribute to the prevention and treatment of urolithiasis by modulating the expression of molecules involved in cell migration, adhesion and related signaling pathways in response to oxalate crystal-induced injury. However, a limitation of the present study is that the modulation of the PI3K/Akt and MAPK (p38 and Erk1/2) signaling pathways, through the examination of phospho-protein levels, was not assessed. Future studies should incorporate western blot or ELISA to assess phosphorylated proteins (p-Akt, p-p38, p-ERK1/2) to provide direct evidence of signaling pathway regulation. This would strengthen the mechanistic understanding of how SGS modulates the expression of molecules in response to oxalate crystal-induced injury.</p>
<p>In conclusions, the present study demonstrated that NaOX exposure altered the expression of cell adhesion molecules and impaired the migration ability of HK-2 cells. Notably, SGS treatment alleviated these effects by restoring cell adhesion molecule expression to near-normal levels and enhancing cell migration. These protective effects are likely mediated through the regulation of the PI3K/Akt and MAPK (p38 and Erk1/2) signaling pathways. Furthermore, the findings highlighted the potential of SGS in the prevention and treatment of urolithiasis, providing valuable new insights into therapeutic strategies for this disease.</p>
</sec>
</body>
<back>
<ack>
<title>Acknowledgements</title>
<p>Not applicable.</p>
</ack>
<sec sec-type="data-availability">
<title>Availability of data and materials</title>
<p>The data generated in the present study may be requested from the corresponding author.</p>
</sec>
<sec>
<title>Authors&#x0027; contributions</title>
<p>TR, JP and WS conceived and designed the experiments. TR, JP, SS and WS performed the experiments. TR, JP, SS, JEA and WS were responsible for the analysis of data. TR and JP participated in the drafting of the manuscript. KW, JK and TR edited and finalized the final version of the manuscript. KW and JK supervised the study. WS provided funding and project administration. TR, JP and WS confirm the authenticity of all the raw data. All authors read and approved the final manuscript.</p>
</sec>
<sec>
<title>Ethics approval and consent to participate</title>
<p>Not applicable.</p>
</sec>
<sec>
<title>Patient consent for publication</title>
<p>Not applicable.</p>
</sec>
<sec sec-type="COI-statement">
<title>Competing interests</title>
<p>The authors declare that they have no competing interests.</p>
</sec>
<ref-list>
<title>References</title>
<ref id="b1-BR-23-2-02001"><label>1</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yasui</surname><given-names>T</given-names></name><name><surname>Okada</surname><given-names>A</given-names></name><name><surname>Hamamoto</surname><given-names>S</given-names></name><name><surname>Ando</surname><given-names>R</given-names></name><name><surname>Taguchi</surname><given-names>K</given-names></name><name><surname>Tozawa</surname><given-names>K</given-names></name><name><surname>Kohri</surname><given-names>K</given-names></name></person-group><article-title>Pathophysiology-based treatment of urolithiasis</article-title><source>Int J Urol</source><volume>24</volume><fpage>32</fpage><lpage>38</lpage><year>2017</year><pub-id pub-id-type="pmid">27539983</pub-id><pub-id pub-id-type="doi">10.1111/iju.13187</pub-id></element-citation></ref>
<ref id="b2-BR-23-2-02001"><label>2</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pandhare</surname><given-names>RB</given-names></name><name><surname>Shende</surname><given-names>RR</given-names></name><name><surname>Avhad</surname><given-names>MS</given-names></name><name><surname>Deshmukh</surname><given-names>VK</given-names></name><name><surname>Mohite</surname><given-names>PB</given-names></name><name><surname>Sangameswaran</surname><given-names>B</given-names></name><name><surname>Daude</surname><given-names>RB</given-names></name></person-group><article-title>Anti-urolithiatic activity of <italic>Bryophyllum pinnatum</italic> Lam. hydroalcoholic extract in sodium oxalate-induced urolithiasis in rats</article-title><source>J Tradit Complement Med</source><volume>11</volume><fpage>545</fpage><lpage>551</lpage><year>2021</year><pub-id pub-id-type="pmid">34765518</pub-id><pub-id pub-id-type="doi">10.1016/j.jtcme.2021.06.002</pub-id></element-citation></ref>
<ref id="b3-BR-23-2-02001"><label>3</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Patel</surname><given-names>VB</given-names></name><name><surname>Acharya</surname><given-names>N</given-names></name></person-group><article-title>Effect of <italic>Macrotyloma uniflorum</italic> in ethylene glycol induced urolithiasis in rats</article-title><source>Heliyon</source><volume>6</volume><issue>e04253</issue><year>2020</year><pub-id pub-id-type="pmid">32637686</pub-id><pub-id pub-id-type="doi">10.1016/j.heliyon.2020.e04253</pub-id></element-citation></ref>
<ref id="b4-BR-23-2-02001"><label>4</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Geraghty</surname><given-names>R</given-names></name><name><surname>Wood</surname><given-names>K</given-names></name><name><surname>Sayer</surname><given-names>JA</given-names></name></person-group><article-title>Calcium oxalate crystal deposition in the kidney: Identification, causes and consequences</article-title><source>Urolithiasis</source><volume>48</volume><fpage>377</fpage><lpage>384</lpage><year>2020</year><pub-id pub-id-type="pmid">32719990</pub-id><pub-id pub-id-type="doi">10.1007/s00240-020-01202-w</pub-id></element-citation></ref>
<ref id="b5-BR-23-2-02001"><label>5</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Costa</surname><given-names>P</given-names></name><name><surname>Blowes</surname><given-names>LM</given-names></name><name><surname>Laly</surname><given-names>AC</given-names></name><name><surname>Connelly</surname><given-names>JT</given-names></name></person-group><article-title>Regulation of collective cell polarity and migration using dynamically adhesive micropatterned substrates</article-title><source>Acta Biomater</source><volume>126</volume><fpage>291</fpage><lpage>300</lpage><year>2021</year><pub-id pub-id-type="pmid">33741539</pub-id><pub-id pub-id-type="doi">10.1016/j.actbio.2021.03.032</pub-id></element-citation></ref>
<ref id="b6-BR-23-2-02001"><label>6</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yao</surname><given-names>W</given-names></name><name><surname>Wang</surname><given-names>Z</given-names></name><name><surname>Ma</surname><given-names>H</given-names></name><name><surname>Lin</surname><given-names>Y</given-names></name><name><surname>Liu</surname><given-names>X</given-names></name><name><surname>Li</surname><given-names>P</given-names></name><name><surname>He</surname><given-names>X</given-names></name></person-group><article-title>Epithelial-mesenchymal plasticity (EMP) in wound healing: Exploring EMT mechanisms, regulatory network, and therapeutic opportunities</article-title><source>Heliyon</source><volume>10</volume><issue>e34269</issue><year>2024</year><pub-id pub-id-type="pmid">39108889</pub-id><pub-id pub-id-type="doi">10.1016/j.heliyon.2024.e34269</pub-id></element-citation></ref>
<ref id="b7-BR-23-2-02001"><label>7</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jayne</surname><given-names>D</given-names></name><name><surname>Herbert</surname><given-names>C</given-names></name><name><surname>Anquetil</surname><given-names>V</given-names></name><name><surname>Teixeira</surname><given-names>G</given-names></name></person-group><article-title>Exploring the critical role of tight junction proteins in kidney disease pathogenesis</article-title><source>Nephron</source><volume>149</volume><fpage>240</fpage><lpage>250</lpage><year>2025</year><pub-id pub-id-type="pmid">39532075</pub-id><pub-id pub-id-type="doi">10.1159/000542498</pub-id></element-citation></ref>
<ref id="b8-BR-23-2-02001"><label>8</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yu</surname><given-names>L</given-names></name><name><surname>Gan</surname><given-names>X</given-names></name><name><surname>Liu</surname><given-names>X</given-names></name><name><surname>An</surname><given-names>R</given-names></name></person-group><article-title>Calcium oxalate crystals induces tight junction disruption in distal renal tubular epithelial cells by activating ROS/Akt/p38 MAPK signaling pathway</article-title><source>Ren Fail</source><volume>39</volume><fpage>440</fpage><lpage>451</lpage><year>2017</year><pub-id pub-id-type="pmid">28335665</pub-id><pub-id pub-id-type="doi">10.1080/0886022X.2017.1305968</pub-id></element-citation></ref>
<ref id="b9-BR-23-2-02001"><label>9</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Qi</surname><given-names>S</given-names></name><name><surname>Wang</surname><given-names>Q</given-names></name><name><surname>Xie</surname><given-names>B</given-names></name><name><surname>Chen</surname><given-names>Y</given-names></name><name><surname>Zhang</surname><given-names>Z</given-names></name><name><surname>Xu</surname><given-names>Y</given-names></name></person-group><article-title>P38 MAPK signaling pathway mediates COM crystal-induced crystal adhesion change in rat renal tubular epithelial cells</article-title><source>Urolithiasis</source><volume>48</volume><fpage>9</fpage><lpage>18</lpage><year>2020</year><pub-id pub-id-type="pmid">31183507</pub-id><pub-id pub-id-type="doi">10.1007/s00240-019-01143-z</pub-id></element-citation></ref>
<ref id="b10-BR-23-2-02001"><label>10</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Liu</surname><given-names>RN</given-names></name><name><surname>Zou</surname><given-names>DM</given-names></name><name><surname>Tian</surname><given-names>MY</given-names></name><name><surname>Li</surname><given-names>K</given-names></name><name><surname>Du</surname><given-names>JL</given-names></name><name><surname>Liu</surname><given-names>MJ</given-names></name><name><surname>Ma</surname><given-names>YZ</given-names></name></person-group><article-title>Effect of magnesium ammonium phosphate on the expression of adhesion molecules in sheep renal tubular epithelial cells</article-title><source>Res Vet Sci</source><volume>138</volume><fpage>167</fpage><lpage>177</lpage><year>2021</year><pub-id pub-id-type="pmid">34153557</pub-id><pub-id pub-id-type="doi">10.1016/j.rvsc.2021.05.021</pub-id></element-citation></ref>
<ref id="b11-BR-23-2-02001"><label>11</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sayed</surname><given-names>AA</given-names></name><name><surname>Soliman</surname><given-names>A.M</given-names></name><name><surname>Fahmy</surname><given-names>SR</given-names></name><name><surname>Hosny</surname><given-names>R</given-names></name></person-group><article-title>Antiurolithiatic effect of a polyherbal formulation against sodium oxalate-induced urolithiasis in rats</article-title><source>J Basic Appl Zool</source><volume>84</volume><issue>15</issue><year>2023</year></element-citation></ref>
<ref id="b12-BR-23-2-02001"><label>12</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gopika</surname><given-names>S</given-names></name><name><surname>Nisha</surname><given-names>MK</given-names></name><name><surname>Gaayathiri Devi</surname><given-names>E</given-names></name><name><surname>Raja Rajeswari</surname><given-names>A</given-names></name><name><surname>Vasandhlakshmi</surname><given-names>R</given-names></name></person-group><article-title>Evaluation of antiurolithiatic potential of methanolic stem extract of <italic>Spermacocce articularis</italic> L.f.: An in vitro and in vivo approach</article-title><source>Pharmacogn J</source><volume>16</volume><fpage>770</fpage><lpage>778</lpage><year>2024</year></element-citation></ref>
<ref id="b13-BR-23-2-02001"><label>13</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wongprasert</surname><given-names>K</given-names></name><name><surname>Rudtanatip</surname><given-names>T</given-names></name><name><surname>Praiboon</surname><given-names>J</given-names></name></person-group><article-title>Immunostimulatory activity of sulfated galactans isolated from the red seaweed Gracilaria fisheri and development of resistance against white spot syndrome virus (WSSV) in shrimp</article-title><source>Fish Shellfish Immunol</source><volume>36</volume><fpage>52</fpage><lpage>60</lpage><year>2014</year><pub-id pub-id-type="pmid">24161778</pub-id><pub-id pub-id-type="doi">10.1016/j.fsi.2013.10.010</pub-id></element-citation></ref>
<ref id="b14-BR-23-2-02001"><label>14</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rudtanatip</surname><given-names>T</given-names></name><name><surname>Pariwatthanakun</surname><given-names>C</given-names></name><name><surname>Somintara</surname><given-names>S</given-names></name><name><surname>Sakaew</surname><given-names>W</given-names></name><name><surname>Wongprasert</surname><given-names>K</given-names></name></person-group><article-title>Structural characterization, antioxidant activity, and protective effect against hydrogen peroxide-induced oxidative stress of chemically degraded Gracilaria fisheri sulfated galactans</article-title><source>Int J Biol Macromol</source><volume>206</volume><fpage>51</fpage><lpage>63</lpage><year>2022</year><pub-id pub-id-type="pmid">35218802</pub-id><pub-id pub-id-type="doi">10.1016/j.ijbiomac.2022.02.125</pub-id></element-citation></ref>
<ref id="b15-BR-23-2-02001"><label>15</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rudtanatip</surname><given-names>T</given-names></name><name><surname>Somintara</surname><given-names>S</given-names></name><name><surname>Sakaew</surname><given-names>W</given-names></name><name><surname>El-Abid</surname><given-names>J</given-names></name><name><surname>Cano</surname><given-names>ME</given-names></name><name><surname>Jongsomchai</surname><given-names>K</given-names></name><name><surname>Wongprasert</surname><given-names>K</given-names></name><name><surname>Kovensky</surname><given-names>J</given-names></name></person-group><article-title>Sulfated galactans from Gracilaria fisheri with supplementation of octanoyl promote wound healing activity in vitro and in vivo</article-title><source>Macromol Biosci</source><volume>22</volume><issue>e2200172</issue><year>2022</year><pub-id pub-id-type="pmid">36066490</pub-id><pub-id pub-id-type="doi">10.1002/mabi.202200172</pub-id></element-citation></ref>
<ref id="b16-BR-23-2-02001"><label>16</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sakaew</surname><given-names>W</given-names></name><name><surname>Phanphak</surname><given-names>J</given-names></name><name><surname>Somintara</surname><given-names>S</given-names></name><name><surname>Hipkaeo</surname><given-names>W</given-names></name><name><surname>Wongprasert</surname><given-names>K</given-names></name><name><surname>Kovensky</surname><given-names>J</given-names></name><name><surname>Pariwatthanakun</surname><given-names>C</given-names></name><name><surname>Rudtanatip</surname><given-names>T</given-names></name></person-group><article-title>Increased sulfation in Gracilaria fisheri sulfated galactans enhances antioxidant and antiurolithiatic activities and protects HK-2 cell death induced by sodium oxalate</article-title><source>Mar Drugs</source><volume>20</volume><issue>382</issue><year>2022</year><pub-id pub-id-type="pmid">35736184</pub-id><pub-id pub-id-type="doi">10.3390/md20060382</pub-id></element-citation></ref>
<ref id="b17-BR-23-2-02001"><label>17</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sheng</surname><given-names>GJ</given-names></name><name><surname>Oh</surname><given-names>YI</given-names></name><name><surname>Chang</surname><given-names>SK</given-names></name><name><surname>Hsieh-Wilson</surname><given-names>LC</given-names></name></person-group><article-title>Tunable heparan sulfate mimetics for modulating chemokine activity</article-title><source>J Am Chem Soc</source><volume>135</volume><fpage>10898</fpage><lpage>10901</lpage><year>2013</year><pub-id pub-id-type="pmid">23879859</pub-id><pub-id pub-id-type="doi">10.1021/ja4027727</pub-id></element-citation></ref>
<ref id="b18-BR-23-2-02001"><label>18</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zaporozhets</surname><given-names>T</given-names></name><name><surname>Besednova</surname><given-names>N</given-names></name></person-group><article-title>Prospects for the therapeutic application of sulfated polysaccharides of brown algae in diseases of the cardiovascular system: Review</article-title><source>Pharm Biol</source><volume>54</volume><fpage>3126</fpage><lpage>3135</lpage><year>2016</year><pub-id pub-id-type="pmid">27252012</pub-id><pub-id pub-id-type="doi">10.1080/13880209.2016.1185444</pub-id></element-citation></ref>
<ref id="b19-BR-23-2-02001"><label>19</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sae-Lao</surname><given-names>T</given-names></name><name><surname>Luplertlop</surname><given-names>N</given-names></name><name><surname>Janvilisri</surname><given-names>T</given-names></name><name><surname>Tohtong</surname><given-names>R</given-names></name><name><surname>Bates</surname><given-names>DO</given-names></name><name><surname>Wongprasert</surname><given-names>K</given-names></name></person-group><article-title>Sulfated galactans from the red seaweed Gracilaria fisheri exerts anti-migration effect on cholangiocarcinoma cells</article-title><source>Phytomedicine</source><volume>36</volume><fpage>59</fpage><lpage>67</lpage><year>2017</year><pub-id pub-id-type="pmid">29157829</pub-id><pub-id pub-id-type="doi">10.1016/j.phymed.2017.09.014</pub-id></element-citation></ref>
<ref id="b20-BR-23-2-02001"><label>20</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Liang</surname><given-names>KH</given-names></name><name><surname>Tso</surname><given-names>HC</given-names></name><name><surname>Hung</surname><given-names>SH</given-names></name><name><surname>Kuan</surname><given-names>II</given-names></name><name><surname>Lai</surname><given-names>JK</given-names></name><name><surname>Ke</surname><given-names>FY</given-names></name><name><surname>Chuang</surname><given-names>YT</given-names></name><name><surname>Liu</surname><given-names>IJ</given-names></name><name><surname>Wang</surname><given-names>YP</given-names></name><name><surname>Chen</surname><given-names>RH</given-names></name><name><surname>Wu</surname><given-names>HC</given-names></name></person-group><article-title>Extracellular domain of EpCAM enhances tumor progression through EGFR signaling in colon cancer cells</article-title><source>Cancer Lett</source><volume>433</volume><fpage>165</fpage><lpage>175</lpage><year>2018</year><pub-id pub-id-type="pmid">29981429</pub-id><pub-id pub-id-type="doi">10.1016/j.canlet.2018.06.040</pub-id></element-citation></ref>
<ref id="b21-BR-23-2-02001"><label>21</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Brown</surname><given-names>TC</given-names></name><name><surname>Sankpal</surname><given-names>NV</given-names></name><name><surname>Gillanders</surname><given-names>WE</given-names></name></person-group><article-title>Functional implications of the dynamic regulation of EpCAM during epithelial-to-mesenchymal transition</article-title><source>Biomolecules</source><volume>11</volume><issue>956</issue><year>2021</year><pub-id pub-id-type="pmid">34209658</pub-id><pub-id pub-id-type="doi">10.3390/biom11070956</pub-id></element-citation></ref>
<ref id="b22-BR-23-2-02001"><label>22</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Erickson</surname><given-names>SB</given-names></name><name><surname>Vrtiska</surname><given-names>TJ</given-names></name><name><surname>Lieske</surname><given-names>JC</given-names></name></person-group><article-title>Effect of Cystone<sup>&#x00AE;</sup> on urinary composition and stone formation over a one year period</article-title><source>Phytomedicine</source><volume>18</volume><fpage>863</fpage><lpage>867</lpage><year>2011</year><pub-id pub-id-type="pmid">21419609</pub-id><pub-id pub-id-type="doi">10.1016/j.phymed.2011.01.018</pub-id></element-citation></ref>
<ref id="b23-BR-23-2-02001"><label>23</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Singh</surname><given-names>A</given-names></name><name><surname>Tandon</surname><given-names>S</given-names></name><name><surname>Kaur</surname><given-names>T</given-names></name><name><surname>Tandon</surname><given-names>C</given-names></name></person-group><article-title>In vitro studies on calcium oxalate induced apoptosis attenuated by <italic>Didymocarpus pedicellata</italic></article-title><source>Biointerface Res Appl Chem</source><volume>12</volume><fpage>7342</fpage><lpage>7355</lpage><year>2022</year></element-citation></ref>
<ref id="b24-BR-23-2-02001"><label>24</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gonz&#x00E1;lez Mosquera</surname><given-names>DM</given-names></name><name><surname>Ortega</surname><given-names>YH</given-names></name><name><surname>Quero</surname><given-names>PC</given-names></name><name><surname>Mart&#x00ED;nez</surname><given-names>RS</given-names></name><name><surname>Luc Pieters</surname><given-names>L</given-names></name></person-group><article-title>Antiurolithiatic activity of <italic>Boldoa purpurascens</italic> aqueous extract: An in vitro and in vivo study</article-title><source>J Ethnopharmacol</source><volume>253</volume><issue>112691</issue><year>2020</year><pub-id pub-id-type="pmid">32092500</pub-id><pub-id pub-id-type="doi">10.1016/j.jep.2020.112691</pub-id></element-citation></ref>
<ref id="b25-BR-23-2-02001"><label>25</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Livak</surname><given-names>KJ</given-names></name><name><surname>Schmittgen</surname><given-names>TD</given-names></name></person-group><article-title>Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method</article-title><source>Methods</source><volume>25</volume><fpage>402</fpage><lpage>408</lpage><year>2001</year><pub-id pub-id-type="pmid">11846609</pub-id><pub-id pub-id-type="doi">10.1006/meth.2001.1262</pub-id></element-citation></ref>
<ref id="b26-BR-23-2-02001"><label>26</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>H</given-names></name><name><surname>Gao</surname><given-names>L</given-names></name><name><surname>Zhao</surname><given-names>C</given-names></name><name><surname>Fang</surname><given-names>F</given-names></name><name><surname>Liu</surname><given-names>J</given-names></name><name><surname>Wang</surname><given-names>Z</given-names></name><name><surname>Zhong</surname><given-names>Y</given-names></name><name><surname>Wang</surname><given-names>X</given-names></name></person-group><article-title>The role of PI3K/Akt signaling pathway in chronic kidney disease</article-title><source>Int Urol Nephrol</source><volume>56</volume><fpage>2623</fpage><lpage>2633</lpage><year>2024</year><pub-id pub-id-type="pmid">38498274</pub-id><pub-id pub-id-type="doi">10.1007/s11255-024-03989-8</pub-id></element-citation></ref>
<ref id="b27-BR-23-2-02001"><label>27</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kang</surname><given-names>J</given-names></name><name><surname>Jia</surname><given-names>X</given-names></name><name><surname>Wang</surname><given-names>N</given-names></name><name><surname>Xiao</surname><given-names>M</given-names></name><name><surname>Song</surname><given-names>S</given-names></name><name><surname>Wu</surname><given-names>S</given-names></name><name><surname>Li</surname><given-names>Z</given-names></name><name><surname>Wang</surname><given-names>S</given-names></name><name><surname>Cui</surname><given-names>SW</given-names></name><name><surname>Guo</surname><given-names>Q</given-names></name></person-group><article-title>Insights into the structure-bioactivity relationships of marine sulfated polysaccharides: A review</article-title><source>Food Hydrocoll</source><volume>123</volume><issue>107049</issue><year>2022</year></element-citation></ref>
<ref id="b28-BR-23-2-02001"><label>28</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>De Ara&#x00FA;jo</surname><given-names>L</given-names></name><name><surname>Costa-Pessoa</surname><given-names>JM</given-names></name><name><surname>de Ponte</surname><given-names>MC</given-names></name><name><surname>Oliveira-Souza</surname><given-names>M</given-names></name></person-group><article-title>Sodium oxalate-induced acute kidney injury associated with glomerular and tubulointerstitial damage in rats</article-title><source>Front Physiol</source><volume>11</volume><issue>1076</issue><year>2020</year><pub-id pub-id-type="pmid">32982795</pub-id><pub-id pub-id-type="doi">10.3389/fphys.2020.01076</pub-id></element-citation></ref>
<ref id="b29-BR-23-2-02001"><label>29</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ji</surname><given-names>Y</given-names></name><name><surname>Fang</surname><given-names>S</given-names></name><name><surname>Yang</surname><given-names>Y</given-names></name><name><surname>Wu</surname><given-names>Z</given-names></name></person-group><article-title>Inactivation of the Wnt/&#x03B2;-catenin signaling contributes to the epithelial barrier dysfunction induced by sodium oxalate in canine renal epithelial cells</article-title><source>J Anim Sci</source><volume>99</volume><fpage>1</fpage><lpage>10</lpage><year>2021</year><pub-id pub-id-type="pmid">34549281</pub-id><pub-id pub-id-type="doi">10.1093/jas/skab268</pub-id></element-citation></ref>
<ref id="b30-BR-23-2-02001"><label>30</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Uwaezuoke</surname><given-names>SN</given-names></name></person-group><article-title>The role of adhesion molecules in nephropathies: The diagnostic applications</article-title><source>Integr Mol Med</source><volume>6</volume><fpage>1</fpage><lpage>5</lpage><year>2019</year></element-citation></ref>
<ref id="b31-BR-23-2-02001"><label>31</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hu</surname><given-names>Q</given-names></name><name><surname>Saleem</surname><given-names>K</given-names></name><name><surname>Pandey</surname><given-names>J</given-names></name><name><surname>Charania</surname><given-names>AN</given-names></name><name><surname>Zhou</surname><given-names>Y</given-names></name><name><surname>He</surname><given-names>C</given-names></name></person-group><article-title>Cell adhesion molecules in fibrotic diseases</article-title><source>Biomedicines</source><volume>11</volume><issue>1995</issue><year>2023</year><pub-id pub-id-type="pmid">37509634</pub-id><pub-id pub-id-type="doi">10.3390/biomedicines11071995</pub-id></element-citation></ref>
<ref id="b32-BR-23-2-02001"><label>32</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Peerapen</surname><given-names>P</given-names></name><name><surname>Thongboonkerda</surname><given-names>V</given-names></name></person-group><article-title>p38 MAPK mediates calcium oxalate crystal-induced tight junction disruption in distal renal tubular epithelial cells</article-title><source>Sci Rep</source><volume>3</volume><issue>1041</issue><year>2013</year><pub-id pub-id-type="pmid">23304432</pub-id><pub-id pub-id-type="doi">10.1038/srep01041</pub-id></element-citation></ref>
<ref id="b33-BR-23-2-02001"><label>33</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tsuji</surname><given-names>H</given-names></name><name><surname>Shimizu</surname><given-names>N</given-names></name><name><surname>Nozawa</surname><given-names>M</given-names></name><name><surname>Umekawa</surname><given-names>T</given-names></name><name><surname>Yoshimura</surname><given-names>K</given-names></name><name><surname>De Velasco</surname><given-names>MA</given-names></name><name><surname>Uemura</surname><given-names>H</given-names></name><name><surname>Khan</surname><given-names>SR</given-names></name></person-group><article-title>Osteopontin knockdown in the kidneys of hyperoxaluric rats leads to reduction in renal calcium oxalate crystal deposition</article-title><source>Urolithiasis</source><volume>42</volume><fpage>195</fpage><lpage>202</lpage><year>2014</year><pub-id pub-id-type="pmid">24619192</pub-id><pub-id pub-id-type="doi">10.1007/s00240-014-0649-0</pub-id></element-citation></ref>
<ref id="b34-BR-23-2-02001"><label>34</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Senbanjo</surname><given-names>LT</given-names></name><name><surname>Chellaiah</surname><given-names>MA</given-names></name></person-group><article-title>CD44: A multifunctional cell surface adhesion receptor is a regulator of progression and metastasis of cancer cells</article-title><source>Front Cell Dev Biol</source><volume>5</volume><issue>18</issue><year>2017</year><pub-id pub-id-type="pmid">28326306</pub-id><pub-id pub-id-type="doi">10.3389/fcell.2017.00018</pub-id></element-citation></ref>
<ref id="b35-BR-23-2-02001"><label>35</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jordan</surname><given-names>AR</given-names></name><name><surname>Racine</surname><given-names>RR</given-names></name><name><surname>Hennig</surname><given-names>MJP</given-names></name><name><surname>Lokeshwar</surname><given-names>VB</given-names></name></person-group><article-title>The role of CD44 in disease pathophysiology and targeted treatment</article-title><source>Front Immunol</source><volume>6</volume><issue>182</issue><year>2015</year><pub-id pub-id-type="pmid">25954275</pub-id><pub-id pub-id-type="doi">10.3389/fimmu.2015.00182</pub-id></element-citation></ref>
<ref id="b36-BR-23-2-02001"><label>36</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hong</surname><given-names>SY</given-names></name><name><surname>Qin</surname><given-names>BL</given-names></name></person-group><article-title>The protective role of dietary polyphenols in urolithiasis: Insights into antioxidant effects and mechanisms of action</article-title><source>Nutrients</source><volume>15</volume><issue>3753</issue><year>2023</year><pub-id pub-id-type="pmid">37686790</pub-id><pub-id pub-id-type="doi">10.3390/nu15173753</pub-id></element-citation></ref>
<ref id="b37-BR-23-2-02001"><label>37</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yasir</surname><given-names>F</given-names></name><name><surname>Wahab</surname><given-names>AT</given-names></name><name><surname>Choudhary</surname><given-names>MI</given-names></name></person-group><article-title>Protective effect of dietary polyphenol caffeic acid on ethylene glycol-induced kidney stones in rats</article-title><source>Urolithiasis</source><volume>46</volume><fpage>157</fpage><lpage>166</lpage><year>2018</year><pub-id pub-id-type="pmid">28616648</pub-id><pub-id pub-id-type="doi">10.1007/s00240-017-0982-1</pub-id></element-citation></ref>
<ref id="b38-BR-23-2-02001"><label>38</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Li</surname><given-names>Y</given-names></name><name><surname>Zhanga</surname><given-names>J</given-names></name><name><surname>Liu</surname><given-names>H</given-names></name><name><surname>Yuan</surname><given-names>J</given-names></name><name><surname>Yin</surname><given-names>Y</given-names></name><name><surname>Wang</surname><given-names>T</given-names></name><name><surname>Cheng</surname><given-names>B</given-names></name><name><surname>Sun</surname><given-names>S</given-names></name><name><surname>Guo</surname><given-names>Z</given-names></name></person-group><article-title>Curcumin ameliorates glyoxylate-induced calcium oxalate deposition and renal injuries in mice</article-title><source>Phytomedicine</source><volume>61</volume><issue>152861</issue><year>2019</year><pub-id pub-id-type="pmid">31029908</pub-id><pub-id pub-id-type="doi">10.1016/j.phymed.2019.152861</pub-id></element-citation></ref>
<ref id="b39-BR-23-2-02001"><label>39</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Peerapen</surname><given-names>P</given-names></name><name><surname>Thongboonkerd</surname><given-names>V</given-names></name></person-group><article-title>Protective roles of trigonelline against oxalate-induced epithelial-to-mesenchymal transition in renal tubular epithelial cells: An in vitro study</article-title><source>Food Chem Toxicol</source><volume>135</volume><issue>110915</issue><year>2020</year><pub-id pub-id-type="pmid">31669600</pub-id><pub-id pub-id-type="doi">10.1016/j.fct.2019.110915</pub-id></element-citation></ref>
<ref id="b40-BR-23-2-02001"><label>40</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>Z</given-names></name><name><surname>Li</surname><given-names>MX</given-names></name><name><surname>Xu</surname><given-names>CZ</given-names></name><name><surname>Zhang</surname><given-names>Y</given-names></name><name><surname>Deng</surname><given-names>Q</given-names></name><name><surname>Sun</surname><given-names>R</given-names></name><name><surname>Hu</surname><given-names>QY</given-names></name><name><surname>Zhang</surname><given-names>SP</given-names></name><name><surname>Zhang</surname><given-names>JW</given-names></name><name><surname>Liang</surname><given-names>H</given-names></name></person-group><article-title>Comprehensive study of altered proteomic landscape in proximal renal tubular epithelial cells in response to calcium oxalate monohydrate crystals</article-title><source>BMC Urol</source><volume>20</volume><issue>136</issue><year>2020</year><pub-id pub-id-type="pmid">32867742</pub-id><pub-id pub-id-type="doi">10.1186/s12894-020-00709-z</pub-id></element-citation></ref>
<ref id="b41-BR-23-2-02001"><label>41</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sun</surname><given-names>XY</given-names></name><name><surname>Xu</surname><given-names>M</given-names></name><name><surname>Ouyang</surname><given-names>JM</given-names></name></person-group><article-title>Effect of crystal shape and aggregation of calcium oxalate monohydrate on cellular toxicity in renal epithelial cells</article-title><source>ACS Omega</source><volume>2</volume><fpage>6039</fpage><lpage>6052</lpage><year>2017</year><pub-id pub-id-type="pmid">30023760</pub-id><pub-id pub-id-type="doi">10.1021/acsomega.7b00510</pub-id></element-citation></ref>
<ref id="b42-BR-23-2-02001"><label>42</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bonnici</surname><given-names>L</given-names></name><name><surname>Suleiman</surname><given-names>S</given-names></name><name><surname>Schembri-Wismayer</surname><given-names>P</given-names></name><name><surname>Cassar</surname><given-names>A</given-names></name></person-group><article-title>Targeting signalling pathways in chronic wound healing</article-title><source>Int J Mol Sci</source><volume>25</volume><issue>50</issue><year>2024</year></element-citation></ref>
<ref id="b43-BR-23-2-02001"><label>43</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sun</surname><given-names>C</given-names></name><name><surname>Liu</surname><given-names>M</given-names></name><name><surname>Sun</surname><given-names>P</given-names></name><name><surname>Yang</surname><given-names>M</given-names></name><name><surname>Yates</surname><given-names>EA</given-names></name><name><surname>Guo</surname><given-names>Z</given-names></name><name><surname>Fernig</surname><given-names>DG</given-names></name></person-group><article-title>Sulfated polysaccharides interact with fibroblast growth factors and protect from denaturation</article-title><source>FEBS Open Bio</source><volume>9</volume><fpage>1477</fpage><lpage>1487</lpage><year>2019</year><pub-id pub-id-type="pmid">31271519</pub-id><pub-id pub-id-type="doi">10.1002/2211-5463.12696</pub-id></element-citation></ref>
<ref id="b44-BR-23-2-02001"><label>44</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Huang</surname><given-names>L</given-names></name><name><surname>Shen</surname><given-names>M</given-names></name><name><surname>Morris</surname><given-names>GA</given-names></name><name><surname>Xie</surname><given-names>J</given-names></name></person-group><article-title>Sulfated polysaccharides: Immunomodulation and signaling mechanisms</article-title><source>Trends Food Sci Technol</source><volume>92</volume><fpage>1</fpage><lpage>11</lpage><year>2019</year></element-citation></ref>
<ref id="b45-BR-23-2-02001"><label>45</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Song</surname><given-names>Q</given-names></name><name><surname>Song</surname><given-names>C</given-names></name><name><surname>Chen</surname><given-names>X</given-names></name><name><surname>Xiong</surname><given-names>Y</given-names></name><name><surname>He</surname><given-names>Z</given-names></name><name><surname>Su</surname><given-names>X</given-names></name><name><surname>Zhou</surname><given-names>J</given-names></name><name><surname>Ke</surname><given-names>H</given-names></name><name><surname>Dong</surname><given-names>C</given-names></name><name><surname>Liao</surname><given-names>W</given-names></name><name><surname>Yang</surname><given-names>S</given-names></name></person-group><article-title>Oxalate regulates crystal-cell adhesion and macrophage metabolism via JPT2/PI3K/AKT signaling to promote the progression of kidney stones</article-title><source>J Pharm Anal</source><volume>14</volume><issue>100956</issue><year>2024</year><pub-id pub-id-type="pmid">39035219</pub-id><pub-id pub-id-type="doi">10.1016/j.jpha.2024.02.010</pub-id></element-citation></ref>
<ref id="b46-BR-23-2-02001"><label>46</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lee</surname><given-names>S</given-names></name><name><surname>Kim</surname><given-names>MS</given-names></name><name><surname>Jung</surname><given-names>SJ</given-names></name><name><surname>Kim</surname><given-names>D</given-names></name><name><surname>Park</surname><given-names>HJ</given-names></name><name><surname>Cho</surname><given-names>D</given-names></name></person-group><article-title>ERK activating peptide, AES16-2M promotes wound healing through accelerating migration of keratinocytes</article-title><source>Sci Rep</source><volume>8</volume><issue>14398</issue><year>2018</year><pub-id pub-id-type="pmid">30258088</pub-id><pub-id pub-id-type="doi">10.1038/s41598-018-32851-y</pub-id></element-citation></ref>
<ref id="b47-BR-23-2-02001"><label>47</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kasowanjete</surname><given-names>P</given-names></name><name><surname>Kumar</surname><given-names>SSD</given-names></name><name><surname>Houreld</surname><given-names>NN</given-names></name></person-group><article-title>A review of photobiomodulation on PI3K/AKT/mTOR in wound healing</article-title><source>J Photochem Photobiol</source><volume>19</volume><issue>100215</issue><year>2024</year></element-citation></ref>
<ref id="b48-BR-23-2-02001"><label>48</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ashraf</surname><given-names>R</given-names></name><name><surname>Kumar</surname><given-names>S</given-names></name></person-group><article-title>Mfn2-mediated mitochondrial fusion promotes autophagy and suppresses ovarian cancer progression by reducing ROS through AMPK/mTOR/ ERK signaling</article-title><source>Cell Mol Life Sci</source><volume>79</volume><issue>573</issue><year>2022</year><pub-id pub-id-type="pmid">36308626</pub-id><pub-id pub-id-type="doi">10.1007/s00018-022-04595-6</pub-id></element-citation></ref>
<ref id="b49-BR-23-2-02001"><label>49</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Guzel</surname><given-names>A</given-names></name><name><surname>Yunusoglu</surname><given-names>S</given-names></name><name><surname>Calapoglu</surname><given-names>M</given-names></name><name><surname>Candan</surname><given-names>IA</given-names></name><name><surname>Onaran</surname><given-names>I</given-names></name><name><surname>Oncu</surname><given-names>M</given-names></name><name><surname>Ergun</surname><given-names>O</given-names></name><name><surname>Oksay</surname><given-names>T</given-names></name></person-group><article-title>Protective effects of quercetin on oxidative stress-induced tubular epithelial damage in the experimental rat hyperoxaluria model</article-title><source>Medicina</source><volume>57</volume><issue>566</issue><year>2021</year><pub-id pub-id-type="pmid">34204866</pub-id><pub-id pub-id-type="doi">10.3390/medicina57060566</pub-id></element-citation></ref>
<ref id="b50-BR-23-2-02001"><label>50</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jing</surname><given-names>GH</given-names></name><name><surname>Liu</surname><given-names>YD</given-names></name><name><surname>Liu</surname><given-names>JN</given-names></name><name><surname>Jin</surname><given-names>YS</given-names></name><name><surname>Yu</surname><given-names>SL</given-names></name><name><surname>An</surname><given-names>RH</given-names></name></person-group><article-title>Puerarin prevents calcium oxalate crystal-induced renal epithelial cell autophagy by activating the SIRT1-mediated signaling pathway</article-title><source>Urolithiasis</source><volume>50</volume><fpage>545</fpage><lpage>556</lpage><year>2022</year><pub-id pub-id-type="pmid">35913552</pub-id><pub-id pub-id-type="doi">10.1007/s00240-022-01347-w</pub-id></element-citation></ref>
<ref id="b51-BR-23-2-02001"><label>51</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>Y</given-names></name><name><surname>Zheng</surname><given-names>J</given-names></name><name><surname>Han</surname><given-names>Y</given-names></name><name><surname>Zhang</surname><given-names>Y</given-names></name><name><surname>Su</surname><given-names>L</given-names></name><name><surname>Hu</surname><given-names>D</given-names></name><name><surname>Fu</surname><given-names>X</given-names></name></person-group><article-title>JAM-A knockdown accelerates the proliferation and migration of human keratinocytes, and improves wound healing in rats via FAK/Erk signaling</article-title><source>Cell Death Dis</source><volume>9</volume><issue>848</issue><year>2018</year><pub-id pub-id-type="pmid">30154481</pub-id><pub-id pub-id-type="doi">10.1038/s41419-018-0941-y</pub-id></element-citation></ref>
</ref-list>
</back>
<floats-group>
<fig id="f1-BR-23-2-02001" position="float">
<label>Figure 1</label>
<caption><p>The structural features of <italic>Gracilaria fisheri</italic> SGS. SGS, sulfated galactan with increased sulfation.</p></caption>
<graphic xlink:href="br-23-02-02001-g00.tif"/>
</fig>
<fig id="f2-BR-23-2-02001" position="float">
<label>Figure 2</label>
<caption><p>The effect of SGS on HK-2 cell migration, evaluated using a scratch wound healing assay. (A) Phase contrast images show the wound distance in HK-2 cells treated with NaOX, SGS + NaOX and Cystone + NaOX at 0, 6, 12 and 24 h after scratching. (B) Bar graphs represent the wound gape at 0, 6, 12 and 24 h after scratching. Data are presented as mean &#x00B1; SEM (n=3) from three independent experiments. <sup>&#x002A;</sup>P&#x003C;0.05 vs. normal control; <sup>&#x0023;</sup>P&#x003C;0.05 vs. NaOX control. Scale bars, 100 &#x00B5;m. SGS, sulfated galactan with increased sulfation; NaOX, sodium oxalate; Control, no treatment; NaOX control, treated with 1.25 mmol/l of NaOX; 100-SGS + NaOX, treated with 100 &#x00B5;g/ml of SGS combined with 1.25 mmol/l of NaOX; 1000-SGS + NaOX, treated with 1,000 &#x00B5;g/ml of SGS combined with 1.25 mmol/l of NaOX; Cystone + NaOX, treated with 100 &#x00B5;g/ml of Cystone combined with 1.25 mmol/l of NaOX.</p></caption>
<graphic xlink:href="br-23-02-02001-g01.tif"/>
</fig>
<fig id="f3-BR-23-2-02001" position="float">
<label>Figure 3</label>
<caption><p>Photomicrographs show the effect of SGS on the Transwell migration of HK-2 cells, stained with toluidine blue O at 24 h, with accompanying graphs quantifying the number of migrated cells. Data are presented as mean &#x00B1; SEM (n=3) from three independent experiments. <sup>&#x002A;</sup>P&#x003C;0.05 vs. normal control; <sup>&#x0023;</sup>P&#x003C;0.05 vs. NaOX control. Scale bar, 500 &#x00B5;m. SGS, sulfated galactan with increased sulfation; NaOX, sodium oxalate; Control, no treatment; NaOX control, treated with 1.25 mmol/l of NaOX; 100-SGS + NaOX, treated with 100 &#x00B5;g/ml of SGS combined with 1.25 mmol/l of NaOX; 1000-SGS + NaOX, treated with 1,000 &#x00B5;g/ml of SGS combined with 1.25 mmol/l of NaOX; Cystone + NaOX, treated with 100 &#x00B5;g/ml of Cystone combined with 1.25 mmol/l of NaOX.</p></caption>
<graphic xlink:href="br-23-02-02001-g02.tif"/>
</fig>
<fig id="f4-BR-23-2-02001" position="float">
<label>Figure 4</label>
<caption><p>mRNA expression levels of adhesion molecules in HK-2 cells treated with NaOX, SGS + NaOX and Cystone + NaOX, assessed by qPCR analysis. The transcription levels of CD44, EpCAM, E-cadherin, vimentin, occludin and ZO-1 are shown. Data are presented as mean &#x00B1; SEM (n=3) from three independent experiments. <sup>&#x002A;</sup>P&#x003C;0.05 vs. normal control; <sup>&#x0023;</sup>P&#x003C;0.05 vs. NaOX control. NaOX, sodium oxalate; SGS, sulfated galactan with increased sulfation; Control, no treatment; NaOX control, treated with 1.25 mmol/l of NaOX; 100-SGS + NaOX, treated with 100 &#x00B5;g/ml of SGS combined with 1.25 mmol/l of NaOX; 1000-SGS + NaOX, treated with 1,000 &#x00B5;g/ml of SGS combined with 1.25 mmol/l of NaOX; Cystone + NaOX, treated with 100 &#x00B5;g/ml of Cystone combined with 1.25 mmol/l of NaOX.</p></caption>
<graphic xlink:href="br-23-02-02001-g03.tif"/>
</fig>
<fig id="f5-BR-23-2-02001" position="float">
<label>Figure 5</label>
<caption><p>Expression levels of adhesion molecules in NaOX-induced HK-2 cells following SGS treatment. (A) Protein expression levels of adhesion molecules in HK-2 cells treated with NaOX, SGS + NaOX and Cystone + NaOX, analyzed by western blotting. (B) Quantitative data of CD44, EpCAM, E-cadherin, vimentin, occludin and ZO-1 normalized to &#x03B2;-actin, with fold changes relative to the control group. Data are presented as mean &#x00B1; SEM (n=3) from three independent experiments. <sup>&#x002A;</sup>P&#x003C;0.05 vs. normal control; <sup>&#x0023;</sup>P&#x003C;0.05 vs. NaOX control. NaOX, sodium oxalate; SGS, sulfated galactan with increased sulfation; Control, no treatment; NaOX control, treated with 1.25 mmol/l of NaOX; 100-SGS + NaOX, treated with 100 &#x00B5;g/ml of SGS combined with 1.25 mmol/l of NaOX; 1000-SGS + NaOX, treated with 1,000 &#x00B5;g/ml of SGS combined with 1.25 mmol/l of NaOX; Cystone + NaOX, treated with 100 &#x00B5;g/ml of Cystone combined with 1.25 mmol/l of NaOX.</p></caption>
<graphic xlink:href="br-23-02-02001-g04.tif"/>
</fig>
<fig id="f6-BR-23-2-02001" position="float">
<label>Figure 6</label>
<caption><p>Distribution of adhesion molecules in NaOX-induced HK-2 cells following SGS treatment. (A) Confocal fluorescence micrographs show the expression of adhesion molecules (CD44, EpCAM, E-cadherin, vimentin, occludin and ZO-1) in HK-2 cells treated with NaOX, SGS + NaOX and Cystone + NaOX. Scale bars, 10 &#x00B5;m. (B) Quantitative analysis of fluorescence intensities for each adhesion molecule. Data are presented as mean &#x00B1; SEM (n=3) from three independent experiments. <sup>&#x002A;</sup>P&#x003C;0.05 vs. normal control; <sup>&#x0023;</sup>P&#x003C;0.05 vs. NaOX control. NaOX, sodium oxalate; SGS, sulfated galactan with increased sulfation; Control, no treatment; NaOX control, treated with 1.25 mmol/l of NaOX; 100-SGS + NaOX, treated with 100 &#x00B5;g/ml of SGS combined with 1.25 mmol/l of NaOX; 1000-SGS + NaOX, treated with 1,000 &#x00B5;g/ml of SGS combined with 1.25 mmol/l of NaOX; Cystone + NaOX, treated with 100 &#x00B5;g/ml of Cystone combined with 1.25 mmol/l of NaOX.</p></caption>
<graphic xlink:href="br-23-02-02001-g05.tif"/>
</fig>
<fig id="f7-BR-23-2-02001" position="float">
<label>Figure 7</label>
<caption><p>Scanning electron microscopy images show morphological changes in HK-2 cells from various treatment groups, including normal control, NaOX control, 100-SGS + NaOX, 1000-SGS + NaOX and Cystone + NaOX. Scale bar, 10 &#x00B5;m. NaOX, sodium oxalate; SGS, sulfated galactan with increased sulfation; Control, no treatment; NaOX control, treated with 1.25 mmol/l of NaOX; 100-SGS + NaOX, treated with 100 &#x00B5;g/ml of SGS combined with 1.25 mmol/l of NaOX; 1000-SGS + NaOX, treated with 1,000 &#x00B5;g/ml of SGS combined with 1.25 mmol/l of NaOX; Cystone + NaOX, treated with 100 &#x00B5;g/ml of Cystone combined with 1.25 mmol/l of NaOX.</p></caption>
<graphic xlink:href="br-23-02-02001-g06.tif"/>
</fig>
<fig id="f8-BR-23-2-02001" position="float">
<label>Figure 8</label>
<caption><p>Expression levels of PI3K/Akt and MAPK signaling proteins in NaOX-induced HK-2 cells following SGS treatment. (A) Protein expression levels of PI3K, Akt, Erk1/2 and p38 in HK-2 cells treated with NaOX, SGS <italic>+</italic> NaOX and Cystone <italic>+</italic> NaOX, assessed by western blotting. (B) Quantitative data of PI3K, Akt, Erk1/2 and p38 normalized to &#x03B2;-actin, with fold changes relative to the control group. Data are presented as mean &#x00B1; SEM (n=3) from three independent experiments. <sup>&#x002A;</sup>P&#x003C;0.05 vs. normal control; <sup>&#x0023;</sup>P&#x003C;0.05 vs. NaOX control. NaOX, sodium oxalate; SGS, sulfated galactan with increased sulfation; Control, no treatment; NaOX control, treated with 1.25 mmol/l of NaOX; 100-SGS + NaOX, treated with 100 &#x00B5;g/ml of SGS combined with 1.25 mmol/l of NaOX; 1000-SGS + NaOX, treated with 1,000 &#x00B5;g/ml of SGS combined with 1.25 mmol/l of NaOX; Cystone + NaOX, treated with 100 &#x00B5;g/ml of Cystone combined with 1.25 mmol/l of NaOX.</p></caption>
<graphic xlink:href="br-23-02-02001-g07.tif"/>
</fig>
<table-wrap id="tI-BR-23-2-02001" position="float">
<label>Table I</label>
<caption><p>Primer sequences used for qPCR analysis.</p></caption>
<table frame="hsides" rules="groups">
<thead>
<tr>
<th align="left" valign="middle">Gene</th>
<th align="center" valign="middle">Sequence</th>
</tr>
</thead>
<tbody>
<tr>
<td align="left" valign="middle">CD44-Forward</td>
<td align="left" valign="middle">5&#x0027;-TGCCGCTTTGCAGGTGTAT-3&#x0027;</td>
</tr>
<tr>
<td align="left" valign="middle">CD44-Reverse</td>
<td align="left" valign="middle">5&#x0027;-GGCCTCCGTCCGAGAGA-3&#x0027;</td>
</tr>
<tr>
<td align="left" valign="middle">EpCAM-Forward</td>
<td align="left" valign="middle">5&#x0027;-ATAACCTGCTCTGAGCGAGTG-3&#x0027;</td>
</tr>
<tr>
<td align="left" valign="middle">EpCAM-Reverse</td>
<td align="left" valign="middle">5&#x0027;-TGAAGTGCAGTCCGCAAACT-3&#x0027;</td>
</tr>
<tr>
<td align="left" valign="middle">E-cadherin-Forward</td>
<td align="left" valign="middle">5&#x0027;-GAACAGCACGTACACAGCCCT-3&#x0027;</td>
</tr>
<tr>
<td align="left" valign="middle">E-caherin-Reverse</td>
<td align="left" valign="middle">5&#x0027;-GCAGAAGTGTCCCTGTTCCAG-3&#x0027;</td>
</tr>
<tr>
<td align="left" valign="middle">Vimentin-Forward</td>
<td align="left" valign="middle">5&#x0027;-AAAACACCCTGCAATCTTTCAGA-3&#x0027;</td>
</tr>
<tr>
<td align="left" valign="middle">Vimentin-Reverse</td>
<td align="left" valign="middle">5&#x0027;-CACTTTGCGTTCAAGGTCAAGAC-3&#x0027;</td>
</tr>
<tr>
<td align="left" valign="middle">Occludin-Forward</td>
<td align="left" valign="middle">5&#x0027;-GTCCAATATTTTGTGGGACAAGG-3&#x0027;</td>
</tr>
<tr>
<td align="left" valign="middle">Occludin-Reverse</td>
<td align="left" valign="middle">5&#x0027;-GGCACGTCCTGTGTGCCT-3&#x0027;</td>
</tr>
<tr>
<td align="left" valign="middle">ZO-1-Forward</td>
<td align="left" valign="middle">5&#x0027;-AGAAGGATGTTTATCGTCGCATT-3&#x0027;</td>
</tr>
<tr>
<td align="left" valign="middle">ZO-1-Reverse</td>
<td align="left" valign="middle">5&#x0027;-CCAAGAGCCCAGTTTTCCAT-3&#x0027;</td>
</tr>
<tr>
<td align="left" valign="middle">GAPDH-Forward</td>
<td align="left" valign="middle">5&#x0027;-GGTGAAGGTCGGTGTGAACG-3&#x0027;</td>
</tr>
<tr>
<td align="left" valign="middle">GAPDH-Reverse</td>
<td align="left" valign="middle">5&#x0027;-CTCGCTCCTGGAAGATGGTG-3&#x0027;</td>
</tr>
</tbody>
</table>
</table-wrap>
<table-wrap id="tII-BR-23-2-02001" position="float">
<label>Table II</label>
<caption><p>List of antibodies used for western blotting and fluorescence analyses.</p></caption>
<table frame="hsides" rules="groups">
<thead>
<tr>
<th align="left" valign="middle">Name</th>
<th align="center" valign="middle">Host</th>
<th align="center" valign="middle">Cat. no.</th>
<th align="center" valign="middle">Supplier</th>
</tr>
</thead>
<tbody>
<tr>
<td align="left" valign="middle">CD44</td>
<td align="center" valign="middle">Rabbit</td>
<td align="center" valign="middle">Ab157107</td>
<td align="left" valign="middle">Abcam</td>
</tr>
<tr>
<td align="left" valign="middle">EpCAM</td>
<td align="center" valign="middle">Rabbit</td>
<td align="center" valign="middle">Ab71916</td>
<td align="left" valign="middle">Abcam</td>
</tr>
<tr>
<td align="left" valign="middle">E-cadherin</td>
<td align="center" valign="middle">Mouse</td>
<td align="center" valign="middle">M3612</td>
<td align="left" valign="middle">Dako (Agilent Technologies, Inc.)</td>
</tr>
<tr>
<td align="left" valign="middle">Vimentin</td>
<td align="center" valign="middle">Mouse</td>
<td align="center" valign="middle">M0725</td>
<td align="left" valign="middle">Dako (Agilent Technologies, Inc.)</td>
</tr>
<tr>
<td align="left" valign="middle">Occludin</td>
<td align="center" valign="middle">Rabbit</td>
<td align="center" valign="middle">71-1500</td>
<td align="left" valign="middle">Thermo Fisher Scientific, Inc.</td>
</tr>
<tr>
<td align="left" valign="middle">ZO-1</td>
<td align="center" valign="middle">Rabbit</td>
<td align="center" valign="middle">40-2200</td>
<td align="left" valign="middle">Thermo Fisher Scientific, Inc.</td>
</tr>
<tr>
<td align="left" valign="middle">PI3K</td>
<td align="center" valign="middle">Rabbit</td>
<td align="center" valign="middle">4255</td>
<td align="left" valign="middle">Cell Signaling Technology, Inc.</td>
</tr>
<tr>
<td align="left" valign="middle">Akt</td>
<td align="center" valign="middle">Rabbit</td>
<td align="center" valign="middle">4058</td>
<td align="left" valign="middle">Cell Signaling Technology, Inc.</td>
</tr>
<tr>
<td align="left" valign="middle">Erk1/2</td>
<td align="center" valign="middle">Rabbit</td>
<td align="center" valign="middle">4695</td>
<td align="left" valign="middle">Cell Signaling Technology, Inc.</td>
</tr>
<tr>
<td align="left" valign="middle">p38</td>
<td align="center" valign="middle">Rabbit</td>
<td align="center" valign="middle">MA5-15177</td>
<td align="left" valign="middle">Thermo Fisher Scientific, Inc.</td>
</tr>
<tr>
<td align="left" valign="middle">&#x03B2;-actin</td>
<td align="center" valign="middle">Rabbit</td>
<td align="center" valign="middle">AF7018</td>
<td align="left" valign="middle">Affinity biosciences</td>
</tr>
<tr>
<td align="left" valign="middle">HRP-conjugated goat anti-rabbit</td>
<td align="center" valign="middle">&#x00A0;</td>
<td align="center" valign="middle">31466</td>
<td align="left" valign="middle">Thermo Fisher Scientific, Inc.</td>
</tr>
<tr>
<td align="left" valign="middle">HRP-conjugated goat anti-mouse</td>
<td align="center" valign="middle">&#x00A0;</td>
<td align="center" valign="middle">31430</td>
<td align="left" valign="middle">Thermo Fisher Scientific, Inc.</td>
</tr>
<tr>
<td align="left" valign="middle">FITC-conjugated goat anti-rabbit</td>
<td align="center" valign="middle">&#x00A0;</td>
<td align="center" valign="middle">12-507</td>
<td align="left" valign="middle">Merck KGaA</td>
</tr>
<tr>
<td align="left" valign="middle">FITC-conjugated goat anti-mouse</td>
<td align="center" valign="middle">&#x00A0;</td>
<td align="center" valign="middle">12-506</td>
<td align="left" valign="middle">Merck KGaA</td>
</tr>
</tbody>
</table>
</table-wrap>
</floats-group>
</article>
